Scholarlink

Background <p>Renal involvement in undifferentiated connective tissue disease (UCTD) is rare and not well characterized, with membranous nephropathy (MN) representing an uncommon but clinically significant manifestation. While exostosin 1/exostosin 2 (EXT 1/EXT 2)-associated MN has been increasingly recognized in systemic autoimmune diseases such as lupus and Sjögren’s syndrome, its association with UCTD has not been previously reported.</p> Case presentation <p>We present the case of a 32-year-old male with UCTD who developed nephrotic syndrome and was found to have exostosin 1/exostosin 2 (EXT 1/EXT 2)-associated membranous nephropathy (MN) on renal biopsy. The patient exhibited serological markers including ANA, anti-SSA/Ro, and anti-ribosomal P protein antibodies, alongside characteristic pathological features of secondary MN with IgG1-dominant deposits and negative PLA2R/THSD7A staining. He was successfully treated with prednisone, tacrolimus, and hydroxychloroquine, achieving significant reduction in proteinuria within two months.</p> Conclusions <p>This case underscores the diagnostic utility of EXT 1/EXT 2 immunohistochemistry in identifying autoimmune-mediated MN in UCTD and supports the use of combined immunosuppressive therapy. To our knowledge, this is the first reported case of EXT 1/EXT 2-associated MN in a patient with UCTD, thereby expanding the spectrum of renal pathology in this condition and underscoring the importance of precise histological classification to guide targeted treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Exostosin 1/exostosin 2-associated membranous nephropathy in undifferentiated connective tissue disease: a case report and literature review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月25日

查看全文
  • Huan Ye,
  • Xinxin Jiang,
  • Binbin Wu,
  • Xiaohui Xie,
  • Zhigui Zheng

摘要

Background

Renal involvement in undifferentiated connective tissue disease (UCTD) is rare and not well characterized, with membranous nephropathy (MN) representing an uncommon but clinically significant manifestation. While exostosin 1/exostosin 2 (EXT 1/EXT 2)-associated MN has been increasingly recognized in systemic autoimmune diseases such as lupus and Sjögren’s syndrome, its association with UCTD has not been previously reported.

Case presentation

We present the case of a 32-year-old male with UCTD who developed nephrotic syndrome and was found to have exostosin 1/exostosin 2 (EXT 1/EXT 2)-associated membranous nephropathy (MN) on renal biopsy. The patient exhibited serological markers including ANA, anti-SSA/Ro, and anti-ribosomal P protein antibodies, alongside characteristic pathological features of secondary MN with IgG1-dominant deposits and negative PLA2R/THSD7A staining. He was successfully treated with prednisone, tacrolimus, and hydroxychloroquine, achieving significant reduction in proteinuria within two months.

Conclusions

This case underscores the diagnostic utility of EXT 1/EXT 2 immunohistochemistry in identifying autoimmune-mediated MN in UCTD and supports the use of combined immunosuppressive therapy. To our knowledge, this is the first reported case of EXT 1/EXT 2-associated MN in a patient with UCTD, thereby expanding the spectrum of renal pathology in this condition and underscoring the importance of precise histological classification to guide targeted treatment.